Orpheris, Inc.
🇺🇸United States
Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)A Clinical Study to Measure the Effect of OP-101 After Being Administered Subcutaneous in Healthy Volunteers
- First Posted Date
- 2020-03-26
- Last Posted Date
- 2021-06-14
- Lead Sponsor
- Orpheris, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT04321980
- Locations
- 🇦🇺
CMAX, Adelaide, South Australia, Australia
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of OP-101 After Intravenous Administration in Healthy Volunteers
- First Posted Date
- 2018-04-18
- Last Posted Date
- 2018-09-17
- Lead Sponsor
- Orpheris, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT03500627
- Locations
- 🇺🇸
Medpace Clinical Pharmacology Unit, Cincinnati, Ohio, United States
News
No news found